HMS (NASDAQ:HMSY) Earns “Outperform” Rating from Credit Suisse Group
Credit Suisse Group reissued their outperform rating on shares of HMS (NASDAQ:HMSY) in a research note published on Wednesday, Briefing.com Automated Import reports.
Other equities analysts have also recently issued research reports about the company. Guggenheim initiated coverage on Patterson Companies in a report on Wednesday, April 17th. They issued a neutral rating and a $23.00 price objective for the company. BidaskClub upgraded Zynerba Pharmaceuticals from a hold rating to a buy rating in a report on Thursday, July 4th. Zacks Investment Research upgraded Garrett Motion from a sell rating to a hold rating in a report on Friday, May 10th. Chardan Capital upgraded HMS from a neutral rating to a buy rating and lifted their price target for the stock from $37.00 to $41.00 in a report on Monday, July 1st. Finally, KeyCorp reiterated a hold rating on shares of Westrock in a report on Monday, June 24th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of Buy and an average price target of $33.57.
Shares of NASDAQ HMSY opened at $33.41 on Wednesday. The company has a market cap of $2.91 billion, a PE ratio of 35.54, a price-to-earnings-growth ratio of 3.02 and a beta of 1.41. The firm has a 50-day moving average of $31.59. The company has a debt-to-equity ratio of 0.34, a current ratio of 5.34 and a quick ratio of 5.34. HMS has a fifty-two week low of $23.00 and a fifty-two week high of $38.15.
In other HMS news, Chairman William C. Lucia sold 22,978 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $31.79, for a total transaction of $730,470.62. Following the completion of the sale, the chairman now directly owns 143,332 shares in the company, valued at $4,556,524.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman William C. Lucia sold 59,862 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $30.31, for a total transaction of $1,814,417.22. Following the sale, the chairman now owns 182,397 shares of the company’s stock, valued at $5,528,453.07. The disclosure for this sale can be found here. Insiders have sold 174,716 shares of company stock valued at $5,418,806 in the last quarter. 2.87% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently modified their holdings of the business. Texas Permanent School Fund lifted its stake in HMS by 4.6% in the fourth quarter. Texas Permanent School Fund now owns 54,908 shares of the business services provider’s stock valued at $1,545,000 after buying an additional 2,393 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its stake in HMS by 674.1% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 49,467 shares of the business services provider’s stock valued at $1,392,000 after buying an additional 43,077 shares during the last quarter. State of Tennessee Treasury Department lifted its stake in HMS by 3.7% in the fourth quarter. State of Tennessee Treasury Department now owns 62,390 shares of the business services provider’s stock valued at $1,755,000 after buying an additional 2,222 shares during the last quarter. Martingale Asset Management L P purchased a new stake in HMS in the fourth quarter valued at approximately $260,000. Finally, Citigroup Inc. lifted its stake in HMS by 3.0% in the fourth quarter. Citigroup Inc. now owns 58,264 shares of the business services provider’s stock valued at $1,639,000 after buying an additional 1,684 shares during the last quarter. Hedge funds and other institutional investors own 95.86% of the company’s stock.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Recommended Story: The mechanics of the bid-ask spread in trading
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.